Latest news with #SabraHealthcareREIT
Business Insider
6 days ago
- Business
- Business Insider
Wells Fargo Sticks to Its Buy Rating for Sabra Healthcare REIT (SBRA)
Wells Fargo analyst maintained a Buy rating on Sabra Healthcare REIT on July 11 and set a price target of $20.00. The company's shares closed last Friday at $18.46. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Currently, the analyst consensus on Sabra Healthcare REIT is a Moderate Buy with an average price target of $19.40, which is a 5.09% upside from current levels. In a report released on July 8, Bank of America Securities also reiterated a Buy rating on the stock with a $20.00 price target. The company has a one-year high of $20.03 and a one-year low of $15.60. Currently, Sabra Healthcare REIT has an average volume of 2.55M. Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SBRA in relation to earlier this year. Most recently, in May 2025, Michael J Foster, a Director at SBRA sold 11,000.00 shares for a total of $200,310.00.
Business Insider
12-07-2025
- Business
- Business Insider
Sabra Healthcare REIT (SBRA) Receives a Buy from Bank of America Securities
In a report released on July 8, Jeffrey Spector from Bank of America Securities reiterated a Buy rating on Sabra Healthcare REIT, with a price target of $20.00. The company's shares closed yesterday at $18.46. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Spector covers the Real Estate sector, focusing on stocks such as Agree Realty, Cousins Properties, and Welltower. According to TipRanks, Spector has an average return of 3.2% and a 46.63% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sabra Healthcare REIT with a $19.67 average price target. The company has a one-year high of $20.03 and a one-year low of $15.60. Currently, Sabra Healthcare REIT has an average volume of 2.55M. Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SBRA in relation to earlier this year. Most recently, in May 2025, Michael J Foster, a Director at SBRA sold 11,000.00 shares for a total of $200,310.00.
Yahoo
13-05-2025
- Business
- Yahoo
Sabra Health Care price target raised to $19 from $18 at Scotiabank
Scotiabank analyst Nicholas Yulico raised the firm's price target on Sabra Health Care (SBRA) to $19 from $18 and keeps a Sector Perform rating on the shares. The firm is adjusting its estimates on U.S. Real Estate & REITs in its coverage following Q1 results, the analyst tells investors. Quarterly results contained some negative surprises, but generally played out as expected, with most companies maintaining FY25 guidance, the firm notes. Real estate fundamentals tend to lag, so many are looking to see the potential impact of the slowing economy on H2 2025 results, the firm adds. Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on SBRA: Disclaimer & DisclosureReport an Issue Sabra Health Care REIT Reports Strong Q1 2025 Results Sabra Healthcare REIT Reports Record Highs and Strong Pipeline Hold Rating on Sabra Healthcare REIT Amid Strong Financials and Strategic Uncertainties Sabra Healthcare REIT Expands Senior Housing Portfolio Sabra Health Care reports Q1 FFO 37c, consensus 36c
